| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $356,702,378 ) (Continued on the next page) |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01MH132500 | Evaluating a Multilevel Communication Campaign to Increase HIV Vaccine Trial Enrollment | 001 | 3 | NIH | 4/7/2025 | $0 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM149357 | Mechanisms underlying chromosome segregation | 002 | 3 | NIH | 8/1/2025 | $352,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 004 | 20 | NIH | 9/2/2025 | $8,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 003 | 20 | NIH | 8/27/2025 | $1,069,209 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 002 | 20 | NIH | 6/25/2025 | $0 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 002 | 20 | NIH | 6/25/2025 | $0 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 001 | 20 | NIH | 5/16/2025 | $141,120 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 001 | 20 | NIH | 5/16/2025 | $698,451 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 000 | 20 | NIH | 11/7/2024 | $141,120 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI069481 | Seattle Clinical Trials Unit | 000 | 20 | NIH | 11/7/2024 | $699,159 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R35GM119835 | Regulation of Protein Synthesis by Synonymous Codon Usage | 001 | 11 | NIH | 5/5/2025 | $425,872 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24CA288185 | Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit | 001 | 3 | NIH | 9/3/2025 | $792,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | D43CA260656 | Cancer Genomics and Genomic Data Science for East Africa | 000 | 4 | NIH | 8/25/2025 | $230,816 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24CA086368 | The Early Detection Research Network: Data Management and Coordinating Center | 010 | 25 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24CA086368 | The Early Detection Research Network: Data Management and Coordinating Center | 009 | 25 | NIH | 8/7/2025 | $9,121,071 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI177095 | Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization | 001 | 2 | NIH | 2/28/2025 | $873,050 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI177095 | Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization | 000 | 1 | NIH | 10/29/2024 | $873,050 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AG088347 | Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia | 000 | 2 | NIH | 6/26/2025 | $820,196 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01AG077920 | The role of the senescent microenvironment on cancer initiating cells in the colon. | 000 | 6 | NIH | 8/15/2025 | $464,341 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 002 | 3 | NIH | 8/1/2025 | $289,470 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 002 | 3 | NIH | 8/1/2025 | $289,470 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 005 | 3 | NIH | 9/22/2025 | $149,834 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 005 | 3 | NIH | 9/22/2025 | $149,836 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 004 | 3 | NIH | 9/1/2025 | $1,586,327 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 003 | 3 | NIH | 8/12/2025 | $299,987 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 002 | 3 | NIH | 8/1/2025 | $7,595,659 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 002 | 3 | NIH | 8/1/2025 | $289,470 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U24HL169645 | MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | 002 | 3 | NIH | 8/1/2025 | $289,470 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 003 | 20 | NIH | 4/15/2025 | $1,000,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 003 | 20 | NIH | 4/15/2025 | $5,399,174 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 003 | 20 | NIH | 4/15/2025 | $636,816 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 001 | 20 | NIH | 11/21/2024 | $3,656,634 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 001 | 20 | NIH | 11/21/2024 | $732,039 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 001 | 20 | NIH | 11/21/2024 | $5,399,174 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 001 | 20 | NIH | 11/21/2024 | $636,816 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 005 | 20 | NIH | 8/20/2025 | $8,473,830 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068617 | HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | 004 | 20 | NIH | 6/25/2025 | $2,531,633 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI186721 | Phylodynamic mechanisms of HIV reservoir seeding and maintenance | 000 | 2 | NIH | 8/12/2025 | $861,239 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R21AI186807 | Characterization of a new CXCR4-specific restriction factor | 000 | 2 | NIH | 7/15/2025 | $220,000 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AG088223 | Tissue Mechanisms of Aging in the Genetic Model C. elegans | 000 | 2 | NIH | 7/31/2025 | $498,790 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01AI175949 | A new humanized mouse model to study HBV gene editing | 000 | 2 | NIH | 8/12/2025 | $843,440 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA289886 | A compass for those with relapsed leukemia after transplant | 000 | 2 | NIH | 6/23/2025 | $701,179 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA285227 | Rational Vaccine Design to prevent HIV-Associated Lymphoma | 000 | 2 | NIH | 3/4/2025 | $647,437 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA285227 | Rational Vaccine Design to prevent HIV-Associated Lymphoma | 001 | 2 | NIH | 5/22/2025 | $0 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01HG013177 | Statistical Methods for Inferring Gene-Phenotype Associations Using Omic Data from Gene Knockout and Human Phenotype Studies | 000 | 3 | NIH | 8/11/2025 | $559,814 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R25LM014210 | SeattleStatSummer for Biomedical Data Science Research Training | 000 | 4 | NIH | 9/12/2025 | $132,840 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | R01CA266452 | Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity | 000 | 4 | NIH | 7/1/2025 | $402,600 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01CA271407 | Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies | 003 | 4 | NIH | 6/3/2025 | $119,054 |
| | 2025 | 2025 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109-4433 | KING | USA | U01CA271407 | Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies | 002 | 4 | NIH | 4/24/2025 | $1,071,493 |
|
